| Influenza vaccine: Where are we and where do we go? M Keshavarz, H Mirzaei, M Salemi, F Momeni, MJ Mousavi, ... Reviews in medical virology 29 (1), e2014, 2019 | 97 | 2019 |
| The immune system as a target for therapy of SARS-CoV-2: a systematic review of the current immunotherapies for COVID-19 AH Mansourabadi, M Sadeghalvad, HR Mohammadi-Motlagh, N Rezaei Life sciences 258, 118185, 2020 | 93 | 2020 |
| Immune microenvironment in different molecular subtypes of ductal breast carcinoma M Sadeghalvad, HR Mohammadi‐Motlagh, N Rezaei Breast cancer research and treatment, 2020 | 52 | 2020 |
| Recent developments in SARS-CoV-2 vaccines: A systematic review of the current studies M Sadeghalvad, AH Mansourabadi, ... Reviews in Medical Virology, 2022 | 40 | 2022 |
| Soybean Bowman-Birk protease inhibitor (BBI): Identification of the mechanisms of BBI suppressive effect on growth of two adenocarcinoma cell lines: AGS and HT29 A Fereidunian, M Sadeghalvad, MO Oscoie, A Mostafaie Archives of medical research 45 (6), 455-461, 2014 | 39 | 2014 |
| An inflammatory triangle in Sarcoidosis: PPAR-γ, Immune microenvironment, and Inflammation P Jabbari, M Sadeghalvad, N Rezaei. Expert Opinion on Biological Therapy, 2021 | 25 | 2021 |
| Introduction on Monoclonal Antibodies M Sadeghalvad, N Rezaei Monoclonal Antibody, 2021 | 21 | 2021 |
| In vivo anti‐inflammatory efficacy of the combined Bowman‐Birk trypsin inhibitor and genistein isoflavone, two biological compounds from soybean M Sadeghalvad, HR Mohammadi‐Motlagh, AG Karaji, A Mostafaie Journal of biochemical and molecular toxicology 33 (12), e22406, 2019 | 18 | 2019 |
| Adverse events associated with immune checkpoint inhibitors in patients with breast cancer: A systematic review and meta-analysis M Balibeglooa, SA Nejadghaderia, M Sadeghalvad, A Soleymanitabar, ... International Immunopharmacology 96, 2021 | 17 | 2021 |
| Long non-coding RNA HOTAIR induces the PI3K/AKT/mTOR signaling pathway in breast cancer cells M Sadeghalvad, K Mansouri, HR Mohammadi-Motlagh, F Noorbakhsh, ... Revista da Associação Médica Brasileira 68, 456-462, 2022 | 15 | 2022 |
| The effect of CYP2C9* 2, CYP2C9* 3, and VKORC1-1639 G> A polymorphism in patients under warfarin therapy in city of Kermanshah Z Hosseinkhani, M Sadeghalvad, F Norooznezhad, R Khodarahmi, ... Research in pharmaceutical sciences 13 (4), 377-384, 2018 | 15 | 2018 |
| Serological and Molecular Tests for COVID-19: a recent update AH Mansourabadi, M Sadeghalvad, HR Mohammadi-Motlagh, AA Amirzargar. Iranian Journal of Immunology 18 (1), 13-33, 2021 | 11 | 2021 |
| β cell and autophagy: What do we know? HR Mohammadi-Motlagh, M Sadeghalvad, N Yavari, R Primavera, ... Biomolecules 13 (4), 649, 2023 | 10 | 2023 |
| Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated? N Omidian, P Mohammadi, M Sadeghalvad, HR Mohammadi-Motlagh Biomedicine & Pharmacotherapy, 113534, 2022 | 8 | 2022 |
| Flow cytometric analysis of innate lymphoid cells: challenges and solutions M Sadeghalvad, D Khijakadze, M Orangi, F Takei Frontiers in Immunology 14, 2023 | 7 | 2023 |
| Erenumab efficacy in migraine headache prophylaxis: A systematic review M Bagherzadeh-Fard, MA Yazdanifar, M Sadeghalvad, N Rezaei International Immunopharmacology 117, 109366, 2023 | 6 | 2023 |
| Novel G6PC3 mutations in patients with congenital neutropenia: case reports and review of the literature SF Maroufi, Z Shaka, H Mojtabavi, M Sadeghalvad, E Rayzan, I Sedighi, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021 | 6 | 2021 |
| Encyclopedia of Infection and Immunity HR Mohammadi-Motlagh, M Sadeghalvad, N Rezaei Elsevier, 2022 | 5 | 2022 |
| Toll Like Receptors M Sadeghalvad, HR Mohammadi‐Motlagh, N Rezaei Encyclopedia of Infection and Immunity, 2021 | 5 | 2021 |
| Structure and Function of the Immune System M Sadeghalvad, HR Mohammadi-Motlagh, N Rezaei Elsevier, 2022 | 4 | 2022 |
Nima RezaeiTehran University of Medical Sciences; Universal Scientific Education and Research Network (USERN)Потвърден имейл адрес: tums.ac.ir
